These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 15753663

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Studies on antitumor activity of rhEndostatin].
    Li HY, Li Y, Liu ZH, Wu HJ, Chen FH, Chen XG.
    Yao Xue Xue Bao; 2002 Oct; 37(10):763-6. PubMed ID: 12567857
    [Abstract] [Full Text] [Related]

  • 4. Anti-tumor effect of a novel soluble recombinant human endostatin: administered as a single agent or in combination with chemotherapy agents in mouse tumor models.
    Ren Z, Wang Y, Jiang W, Dai W, Jiang Y.
    PLoS One; 2014 Oct; 9(9):e107823. PubMed ID: 25229620
    [Abstract] [Full Text] [Related]

  • 5. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.
    Plum SM, Hanson AD, Volker KM, Vu HA, Sim BK, Fogler WE, Fortier AH.
    Clin Cancer Res; 2003 Oct 01; 9(12):4619-26. PubMed ID: 14555538
    [Abstract] [Full Text] [Related]

  • 6. A quantitative method for measuring the antitumor potency of recombinant human endostatin in vivo.
    Xu YF, Zhu LP, Hu B, Rong ZG, Zhu HW, Xu JM, Wu ZW, Wang JJ, Xu GX.
    Eur J Pharmacol; 2007 Jun 14; 564(1-3):1-6. PubMed ID: 17346697
    [Abstract] [Full Text] [Related]

  • 7. Bioactivity, pharmacokinetics, and immunogenicity assays in preclinical and clinical trials for recombinant human endostatin.
    Hu B, Zhu HW, Zhu LP, Li C, Rong ZG, Xu JM, Wu ZW, Wang JJ, Xu GX.
    Acta Pharmacol Sin; 2008 Nov 14; 29(11):1357-69. PubMed ID: 18954531
    [Abstract] [Full Text] [Related]

  • 8. Expression of soluble, biologically active recombinant human endostatin in Escherichia coli.
    Xu HM, Zhang GY, Ji XD, Cao L, Shu L, Hua ZC.
    Protein Expr Purif; 2005 Jun 14; 41(2):252-8. PubMed ID: 15866710
    [Abstract] [Full Text] [Related]

  • 9. Liposome transfected to plasmid-encoding endostatin gene combined with radiotherapy inhibits liver cancer growth in nude mice.
    Zheng AQ, Song XR, Yu JM, Wei L, Wang XW.
    World J Gastroenterol; 2005 Jul 28; 11(28):4439-42. PubMed ID: 16038050
    [Abstract] [Full Text] [Related]

  • 10. Effects of recombinant human endostatin on a human neuroblastoma xenograft.
    Kuroiwa M, Ikeda H, Hongo T, Tsuchida Y, Hirato J, Kaneko Y, Suzuki N, Obana K, Makino SI.
    Int J Mol Med; 2001 Oct 28; 8(4):391-6. PubMed ID: 11562777
    [Abstract] [Full Text] [Related]

  • 11. Anti-proliferative effect of recombinant human endostatin on synovial fibroblasts in rats with adjuvant arthritis.
    Huang XY, Zhang XM, Chen FH, Zhou LL, Deng XF, Liu YJ, Li XJ.
    Eur J Pharmacol; 2014 Jan 15; 723():7-14. PubMed ID: 24239715
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effect of recombinant human endostatin on the proliferation of hypertrophic scar fibroblasts in a rabbit ear model.
    Gong YF, Zhang XM, Liu F, Wang ZZ, Deng XF, Jiao Y, Li XJ, Huang XY.
    Eur J Pharmacol; 2016 Nov 15; 791():647-654. PubMed ID: 27693124
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Continuous versus intermittent administration of human endostatin in xenografted human neuroblastoma.
    Kuroiwa M, Takeuchi T, Lee JH, Yoshizawa J, Hirato J, Kaneko S, Choi SH, Suzuki N, Ikeda H, Tsuchida Y.
    J Pediatr Surg; 2003 Oct 15; 38(10):1499-505. PubMed ID: 14577075
    [Abstract] [Full Text] [Related]

  • 16. Mouse endostatin inhibits the formation of lung and liver metastases.
    Yoon SS, Eto H, Lin CM, Nakamura H, Pawlik TM, Song SU, Tanabe KK.
    Cancer Res; 1999 Dec 15; 59(24):6251-6. PubMed ID: 10626820
    [Abstract] [Full Text] [Related]

  • 17. Preparation and stability of N-terminal mono-PEGylated recombinant human endostatin.
    Nie Y, Zhang X, Wang X, Chen J.
    Bioconjug Chem; 2006 Dec 15; 17(4):995-9. PubMed ID: 16848407
    [Abstract] [Full Text] [Related]

  • 18. Antitumor interaction of short-course endostatin and ionizing radiation.
    Hanna NN, Seetharam S, Mauceri HJ, Beckett MA, Jaskowiak NT, Salloum RM, Hari D, Dhanabal M, Ramchandran R, Kalluri R, Sukhatme VP, Kufe DW, Weichselbaum RR.
    Cancer J; 2000 Dec 15; 6(5):287-93. PubMed ID: 11079167
    [Abstract] [Full Text] [Related]

  • 19. Soluble multimer of recombinant endostatin expressed in E. coli has anti-angiogenesis activity.
    Wei DM, Gao Y, Cao XR, Zhu NC, Liang JF, Xie WP, Zhen MY, Zhu MS.
    Biochem Biophys Res Commun; 2006 Jul 14; 345(4):1398-404. PubMed ID: 16723120
    [Abstract] [Full Text] [Related]

  • 20. Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery.
    Li L, Huang JL, Liu QC, Wu PH, Liu RY, Zeng YX, Huang WL.
    World J Gastroenterol; 2004 Jul 01; 10(13):1867-71. PubMed ID: 15222025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.